Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance

被引：0
|
作者：
Taylor, Karen J. [1 ]
Lyttle, Nicola [2 ]
Lao, Linda [2 ]
Gourley, Charlie [1 ]
Cameron, David A. [1 ]
Bartlett, John M. S. [2 ]
Spears, Melanie [2 ]
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Ontario Inst Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P6-03-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-03-21
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mechanisms of cell death in breast cancer models of acquired resistance to the taxane drugs
    Rechache, Nesrin
    Riggins, Rebecca
    Zwart, Alan
    Clarke, Robert
    CANCER RESEARCH, 2009, 69
  • [2] Identification of preclinical mechanisms driving acquired resistance to endocrine therapy in estrogen-receptor positive (ER plus ) breast cancer cells
    Ong, C.
    Daemen, A.
    Merrick, K.
    O'Brien, T.
    Friedman, L.
    Hatzivassiliou, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [3] Mechanisms of Acquired Resistance to Venetoclax in Preclinical AML Models
    Zhang, Qi
    Pan, Rongqing
    Han, Lina
    Shi, Ce
    Kurtz, Stephen E.
    Mu, Hong
    Ma, Helen
    Andreeff, Michael
    Leverson, Joel
    Tyner, Jeffrey W.
    Mi, Yingchang
    Konopleva, Marina
    BLOOD, 2015, 126 (23)
  • [4] Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance
    LeBeau, Aaron M.
    Sevillano, Natalia
    King, Mandy L.
    Duriseti, Sai
    Murphy, Stephanie T.
    Craik, Charles S.
    Murphy, Laura L.
    VanBrocklin, Henry F.
    THERANOSTICS, 2014, 4 (03): : 267 - 279
  • [5] MicroRNAs associated with acquired taxane resistance in a breast cancer cell line model
    Taylor, K. J.
    Chong, T.
    D'Costa, A.
    Yao, C.
    Gourley, C.
    Cameron, D. A.
    Bartlett, J. M. S.
    Spears, M.
    CANCER RESEARCH, 2017, 77
  • [6] Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
    Murray, S.
    Briasoulis, E.
    Linardou, H.
    Bafaloukos, D.
    Papadimitriou, C.
    CANCER TREATMENT REVIEWS, 2012, 38 (07) : 890 - 903
  • [7] Identification of acquired chemoresistance mechanisms in patient-derived organoid models of pancreatic adenocarcinoma
    Wansch, Katharina
    Neumann, Christopher
    Doelvers, Florian
    Stintzing, Sebastian
    Keilholz, Ulrich
    Pelzer, Uwe
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 73 - 74
  • [8] Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance
    Raman, Dayanidhi
    Cimpean, Anca Maria
    De Miglio, Maria Rosaria
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [9] Chemoresistance mechanisms of breast cancer and their countermeasures
    Ji, Xiwei
    Lu, Yuan
    Tian, Huifang
    Meng, Xiangrui
    Wei, Minji
    Cho, William C.
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [10] Models and mechanisms of acquired antihormone resistance in breast cancer: significant clinical progress despite limitations
    Sweeney, Elizabeth E.
    McDaniel, Russell E.
    Maximov, Philipp Y.
    Fan, Ping
    Jordan, V. Craig
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2012, 9 (02) : 143 - 163
12345